Abstract:Introduction: Suicidal ideation, an important risk factor for suicide attempts, has an unclear neurobiological basis and is potentially linked to the dysregulation of the hypothalamic-pituitary-adrenal (HPA) axis and immune-inflammatory systems. While inflammatory markers have been associated with suicide attempts and, to a lower extent suicidal ideation, the data on the role of a stress-response system is less robust, with most studies carried out with cortisol showing inconsistent results. The present study extends on the previous studies implicating stress-response and immune-inflammatory systems in suicidal thoughts and behaviours, focusing on the associations of several stress-response (adrenocorticotropic hormone (ACTH), cortisol, and dehydroepiandrosterone (DHEA)) and immune-inflammatory (C-reactive protein (CRP),interle ukin-6 (IL-6), and tumour necrosis factor-alpha (TNF-alpha)) with suicidal ideation severity in recent suicide attempters, patients with major depressive disorder, and non-psychiatric controls. Methods: This observational study included 156 adults from three Vilnius hospitals, recruited into one of the three groups in equal parts: recent suicide attempters, patients with major depressive disorder in current depressive episode, and non-psychiatric controls. Measures included the Hamilton Depression Rating Scale (HDRS-17) and the Beck Scale for Suicide Ideation/Suicide Severity Index (BSS/SSI), alongside sociodemographic data, alcohol, tobacco use, and morning blood samples, measuring plasma ACTH, cortisol, DHEA, CRP, and IL-6. Data were analysed with non-parametric tests, Kendall's tau correlation, and multivariate linear regression adjusted for confounders. Results: We found a negative correlation between the plasma ACTH levels and suicidal ideation severity (tau = -0.130, p = 0.033), which was driven by the patients with major depressive disorder (tau = -0.237, p = 0.031). Suicidal ideation severity was also negatively correlated with TNF-alpha (tau = -0.231; p < 0.001), positively correlated with IL-6 (tau = 0.154, p = 0.015), and CRP levels (tau = 0.153, p = 0.015), but no differences were observed in group-stratified analyses. The association between plasma ACTH levels and suicidal ideation severity in patients with major depressive disorder remained robust to adjustment for major confounders (adjusted for age, sex, education years, body mass index, smoking status, plasma CRP and PEth concentration (measuring chronic alcohol exposure), and antidepressant use) in the linear regression model (t = -2.71, p = 0.011), as well as additionally adjusting for depression severity (t = -2.99, p = 0.006). Discussion: The present study shows an association between plasma ACTH levels and suicidal ideation severity in patients with major depressive disorder, robust to adjustment for antidepressant use and depression severity. This finding highlights the potential role of ACTH, in elucidating the effects of stress and mental health disorders. Our findings underscore the importance of the HPA axis in the diagnosis and treatment of suicidal ideation in major depressive disorder and invite further research on interventions targeting this pathway.

Higher levels of plasma Adrenocorticotropic hormone (ACTH) are associated with lower suicidal ideation in depressed patients compared to controls and suicide attempters, independently from depression severity

478. Elevated Plasma Adrenocorticotropic Hormone (ACTH) Levels Correlate With Reduced Suicidal Thoughts in Psychiatric Patients Relative to Control Groups, Regardless of Depression Intensity

Ndt_a_219962 2893..2900

Certain immune parameters may have a significant impact on suicidal behaviour - a naturalistic study among psychiatric in-patients

The impact of ACTH levels on neurotransmitters and antioxidants in patients with major depressive disorder: A novel investigation

Hypothalamic‐pituitary‐adrenal and ‐thyroid Axis Dysfunctions and Decrements in the Availability of L‐tryptophan As Biological Markers of Suicidal Ideation in Major Depressed Females

Association between cytokines and suicidality in patients with psychosis: A multicentre longitudinal analysis

The Changes In, and Relationship Between, Plasma Nitric Oxide and Corticotropin‐releasing Hormone in Patients with Major Depressive Disorder

Investigation of peripheral inflammatory biomarkers in association with suicide risk in major depressive disorder

Plasma kynurenine levels are elevated in suicide attempters with major depressive disorder

Catecholamine and HPA Axis Dysfunction in Depression: Relationship with Suicidal Behavior

Increased C‐reactive Protein Concentration and Suicidal Behavior in People with Psychiatric Disorders: A Systematic Review and Meta‐analysis

Prolactin and thyroid hormone levels are associated with suicide attempts in psychiatric patients

Associations among serum markers of inflammation, life stress and suicide risk in patients with major depressive disorder

Can high-sensitivity C-reactive protein be a routine trans-diagnostic biomarker for thoughts of death and suicidal attempts?

Investigation of peripheral inflammatory biomarkers in association with suicide risk in major depression

Hypothalamo-pituitary-adrenal function in patients with depressive disorders is correlated with baseline cytokine levels, but not with cytokine responses to hydrocortisone

The Differences in Testosterone and Stress Hormones Between Unipolar and Bipolar Depression in Adolescents and Adults

Inflammation biomarkers in suicide attempts and their relation to abuse, global functioning and cognition

Effect of Dysregulation of Hypothalamus-Pituitary-adrenal(hpa) Axis on the Differentiation and Development of T-helper Cell 17 in Depressive Disorder Patients

Relationships Between Interleukin-6 Activity, Acute Phase Proteins, and Function of the Hypothalamic-Pituitary-adrenal Axis in Severe Depression.